Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
ACS Applied Bio Materials|February 13, 2026
Theoretical and Experimental Studies of Aliovalent Effects in Color Tuning and Biocompatibility of Eu<sup>3<b>+</b></sup>-Doped SrZrO<sub>3</sub> PerovskiteAswin Raj Irudayaraj, Chandan Kumar Yadav, Brindaban Modak, et al.
Biochemical and Biophysical Research Communications|June 10, 2025
"The role of long non-coding RNAs in mediating epigenetic changes induced by bisphenol A Exposure: Focus on reproductive and neurodevelopmental outcomes"Yash Banabakode, Sharine Priscilla, Kunka Mohanram Ramkumar, et al.
Current Colorectal Cancer Reports|January 10, 2015
Histone Demethylases in Colon CancerSantanu Paul, Satish Ramalingam, Dharmalingam Subramaniam, et al.
Discover Oncology|June 13, 2024
Repurposing FDA-approved compounds to target JAK2 for colon cancer treatmentBavya Chandrasekhar, Ravi Gor, Satish Ramalingam, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 6, 2023
Therapeutic potentials of stem cell-derived exosomes in cardiovascular diseasesSaiprahalad Mani, Narasimman Gurusamy, Thennavan Ulaganathan, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|April 26, 2021
Ameliorative role of ellagic acid against acute liver steatosis in adult zebrafish experimental modelAishwarya Venkatasubramanian, Anand Thiyagaraj, Vairamuthu Subbiah, et al.
Microrna (Shariqah, United Arab Emirates)|February 20, 2025
MicroRNA-Mediated Regulation of Cancer Stem Cells: Implications for Radioresistance and Chemoresistance in Cancer TreatmentVasanth Kanth Thasma Loganathbabu, Harin N Ganesh, Ravi Gor, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 8, 2008
CUGBP2 downregulation by prostaglandin E2 protects colon cancer cells from radiation-induced mitotic catastropheGopalan Natarajan, Satish Ramalingam, Ilangovan Ramachandran, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 28, 2025
Identification of Flavonoid-based Hypoxia-inducible Factor-2 Alpha Inhibitors for the Treatment of Breast Cancer- In silico and In vitro EvidenceShahinaz, Mursaleen Baba, Ravi Gor, et al.
Pageof 6